Inteliphage SRL
16.1 FTEThe score of Inteliphage shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +368 % Headcount (avg FTE) +293 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inteliphage's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 22,546 € | ||||
| Net result | −€2.02m | ||||
| Equity | €3.19m | ||||
| Cash | 597,188 € | ||||
| EBITDA | −€1.74m | ||||
| Total assets | €12.6m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 24 Oct 2025
- Year ended 31 Dec 2023filed on 27 Nov 2024
- Year ended 31 Dec 2022filed on 22 Nov 2023
- Year ended 31 Dec 2021filed on 10 Oct 2022
Inteliphage's financial analysis
- Solvency25.2%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inteliphage
Inteliphage's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0692.975.522
- VAT number
- BE0692975522
- Peppol
- Registered · 0208:0692975522 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Mar 2018
- Registered office
- 1348 Ottignies-Louvain-la-Neuve
- Size
- Small · 16.1 FTE
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Inteliphage (SRL) has been based in Ottignies-Louvain-la-Neuve since 2018, active in: manufacture of basic pharmaceutical products. For 2025, it reports revenue of 22,546 €, a net loss of €2.02m and equity of €3.19m. With 16.1 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 25.2%, below the median of its sector (38.7%).
Companies similar to Inteliphage
Companies in the same business, of comparable size and area, outside its group.
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Apotheek Dessein Retail sale of pharmaceutical products Beernem · balance sheet €9.75m
- Pharmacie Houba Retail sale of pharmaceutical products Brussels · balance sheet €8.75m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Inveda Retail sale of pharmaceutical products Ostend · balance sheet €13.6m
- Pharmacies Servais Retail sale of pharmaceutical products Wavre · balance sheet €28.6m
- Tilman Manufacture of pharmaceutical preparations Somme-Leuze · balance sheet €43.2m
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
Frequently asked questions about Inteliphage
What is the revenue of Inteliphage?
According to the 2025 annual accounts filed with the NBB, the revenue of Inteliphage amounts to 22,546 €.
What is the VAT number of Inteliphage?
In Belgium, the VAT number is the company number prefixed with BE: BE0692975522 for Inteliphage, if the company is VAT-registered. Its company number (CBE) is 0692.975.522.
Where is the registered office of Inteliphage?
According to the CBE register, the registered office of Inteliphage is in 1348 Ottignies-Louvain-la-Neuve.
What is the equity of Inteliphage?
At the close of the 2025 financial year, the equity of Inteliphage amounts to 3,186,821 €, a solvency of 25.2% of total assets.
How many people work at Inteliphage?
16.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Inteliphage?
The register lists 7 active mandates at Inteliphage. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inteliphage
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →